NanJing Public Utilities Development (000421)
Search documents
南京公用(000421) - 董事会议事规则
2025-06-12 09:31
南京公用发展股份有限公司 董事会议事规则 二○二五年六月 南京公用发展股份有限公司 董事会议事规则 第一章 总则 第一条 为进一步明确南京公用发展股份有限公司(以下简称"公司")董 事会的职权范围,规范董事会内部机构及运作程序,确保董事会的工作效率和科 学决策,充分发挥董事会的经营决策中心作用,根据《公司法》《证券法》以及 《公司章程》等有关规定,制定本规则。 第二章 董事会的组成和职权 第二条 公司依法设立董事会,是公司经营管理的决策机构,董事会在《公 司章程》和股东会的授权范围内,负责经营和管理公司的财产,对股东会负责。 第三条 公司董事会由九名董事组成,其中独立董事三名。董事会设董事长 一名。 第四条 董事会下设战略与 ESG、审计、提名、薪酬与考核四个专门委员会。 专门委员会成员全部由董事组成,其中审计委员会、薪酬与考核委员会、提 名委员会中独立董事应占多数并担任召集人,审计委员会中至少应有一名独立董 事是会计专业人士。 第五条 董事会行使下列职权: (一)召集股东会,并向股东会报告工作; (二)执行股东会的决议; (三)决定公司的经营计划和投资方案; (四)制订公司的利润分配方案和弥补亏损方案; ( ...
南京公用(000421) - 关联交易管理制度
2025-06-12 09:31
南京公用发展股份有限公司 关联交易管理制度 二○二五年六月 南京公用发展股份有限公司 关联交易管理制度 第一章 总则 第一条 为规范南京公用发展股份有限公司(以下简称"公司")的关联交易, 保证公司关联交易符合公平、公正、公开的原则,维护公司及公司全体股东的合 法权益,根据《中华人民共和国公司法》《中华人民共和国证券法》《深圳证券 交易所股票上市规则》《深圳证券交易所上市公司自律监管指引第1号——主板 上市公司规范运作》《深圳证券交易所上市公司自律监管指引第7号——交易与 关联交易》等法律、规章及《公司章程》的有关规定,结合公司的实际情况,制 定本制度。 第二条 本制度所称关联交易,是指公司及其控股子公司与公司关联人之间 发生的转移资源或义务的事项。 第六条 具有以下情形之一的法人,为公司的关联法人: (一)直接或间接地控制公司的法人或其他组织; (二)由前项所述法人直接或间接控制的除公司及其控股子公司以外的法人 或其他组织; (三)由本制度第七条所列公司的关联自然人直接或间接控制的,或担任董 事(不含同为双方的独立董事)、高级管理人员的,除公司及其控股子公司以外 的法人或其他组织; 第三条 公司发生关联交易 ...
A股内幕交易刷新历史:“提前涨停”已成日常?
阿尔法工场研究院· 2025-06-10 10:19
Core Viewpoint - The article highlights the rampant insider trading in the A-share market, indicating that the frequency and audacity of such activities have reached unprecedented levels, overshadowing previous regulatory efforts [3][22]. Group 1: Instances of Pre-announcement Price Surge - Guokewi announced on June 6 its intention to acquire 94.366% of Zhongxin Ningbo's equity, leading to a 20% price surge on May 20, just before the announcement [5]. - Shangluo Electronics saw a 22.82% increase over four trading days prior to its announcement on June 4 regarding the acquisition of Guangzhou Ligong Technology [6]. - Bangji Technology's stock price surged on June 4 before announcing its acquisition plans [7]. - ST Jinbi experienced a 7.13% increase in the two trading days leading up to its announcement on June 4 regarding a share transfer [8]. - Huamao Technology's stock rose by 11.16% in the three trading days before its June 4 announcement of acquiring Shenzhen Fuchuang Youyue Technology [9]. Group 2: Long-term Price Increases Before Major Announcements - Honghui Fruits and Vegetables saw a 38.14% increase from April 1 to June 6, despite only a 2.97% rise on the announcement day [23]. - Maipu Medical's stock surged over 69.61% from April 7 to May 21, with significant increases noted before its announcement [23]. - Haitai Development's stock rose by 73.84% from April 7 to June 5, despite only a 1.73% increase on the announcement day [23]. - Feiyada's stock increased by 50.76% in May, with multiple days of over 9% gains leading up to its announcement on June 4 [23]. Group 3: Techniques of Insider Trading - The article discusses the strategy of creating false market signals to mislead investors, as seen in the case of Qunxing Toys, which experienced a sudden surge in trading volume before announcing a major asset restructuring [29]. - The practice of buying shares before creating favorable news is highlighted, with examples such as Diou Home, where the actual controller's shareholding was transferred to a related party [31]. - The article notes that insider trading is often concealed effectively, making it difficult for regulatory bodies to detect [34]. Group 4: Regulatory Challenges - The article emphasizes that even significant price increases do not necessarily trigger regulatory scrutiny, as companies can claim no insider information was leaked [36][38]. - Instances of companies reporting substantial price increases before announcements without facing consequences illustrate the challenges in enforcing regulations [40][41].
南京公用(000421) - 关于发行股份及支付现金购买资产并募集配套资金暨关联交易的进展公告
2025-06-08 07:45
证券代码:000421 证券简称:南京公用 公告编号:2025-39 南京公用发展股份有限公司 关于发行股份及支付现金购买资产并募集配套资金暨关 联交易的进展公告 2、截至本公告披露之日,除本次交易预案披露的风险因素外,公司尚未发现可 能导致公司董事会或者交易对方撤销、中止本次交易或者对本次交易方案作出实质 性变更的相关事项。本次交易相关工作正在进行中,公司将根据相关事项的进展情 况,及时履行信息披露义务。 3、本次交易涉及的尽职调查、审计、评估等相关工作尚未完成,且本次交易尚 需公司董事会再次审议及公司股东大会审议批准,并取得有权国有资产监督管理部 门的核准,经深圳证券交易所审核通过和中国证监会予以注册后方可实施。本次交 易能否获得相关部门的批准,以及最终获得批准的时间存在不确定性,敬请投资者 注意投资风险。 一、本次交易概述 公司拟通过发行股份及支付现金方式向刘爱明等 22 名交易对方购买其合计持 有的宇谷科技 20,399,997 股股份(占宇谷科技总股本比例为 68%)并募集配套资金。 根据《上市公司重大资产重组管理办法》《深圳证券交易所股票上市规则》等 法律、法规及规范性文件的相关规定,本次发行股份 ...
南京公用(000421) - 关于2021年限制性股票激励计划第三个解除限售期限制性股票回购注销完成的公告
2025-05-28 09:17
证券代码:000421 股票简称:南京公用 公告编号:2025-38 南京公用发展股份有限公司 关于 2021 年限制性股票激励计划第三个解除限售期限 制性股票回购注销完成的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完 整,没有虚假记载、误导性陈述或重大遗漏。 特别提示: 1、本次回购注销的限制性股票数量为 1,645,260 股,占回购注销前公司总股本 的比例为 0.2856%,共涉及 110 名激励对象,其中:1 名因组织调动离职人员第三个 解除限售期所对应的 9,520 股限制性股票的回购价格为 2.12 元/股加上银行同期定 期存款利息;109 名激励对象(不含 1 名因组织调动离职的激励对象)第三个解除限 售期所对应的 1,635,740 股限制性股票的回购价格为 2.12 元/股。 2、本次回购注销完成后,公司总股本变更为 574,415,734 股。 3、截至本公告披露日,公司已在中国证券登记结算有限责任公司深圳分公司办 理完成上述限制性股票的回购注销手续。 一、本激励计划已履行的相关审批程序 1、2021 年 12 月 30 日,公司召开了第十一届董事会第八次会议和第十一届监 ...
南京公用发展股份有限公司 董事会决议公告
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2025-05-28 00:09
Group 1 - The board of directors of Nanjing Public Utilities Development Co., Ltd. held its 11th meeting of the 12th session on May 27, 2025, with all 9 directors present, complying with the requirements of the Company Law and the Articles of Association [2][4] - The board approved a proposal to change the registered capital and business scope, as well as to amend the Articles of Association, aiming to enhance the company's governance structure and operational standards [3][21] - The registered capital was reduced from 576,060,994 yuan to 574,415,734 yuan due to the repurchase and cancellation of 1,645,260 shares from the 2021 restricted stock incentive plan [21][22] Group 2 - The board approved the establishment and revision of several governance systems, including the rules for shareholder meetings, board meetings, independent director systems, and various management regulations [6][14] - The company plans to absorb and merge its wholly-owned subsidiary, Nanjing Jinguang Industrial Co., Ltd., with the authorization for management to handle all related matters [15][17] - A temporary shareholders' meeting is scheduled for June 12, 2025, to discuss the approved proposals [17][18]
南京公用(000421) - 关于吸收合并全资子公司南京金宫实业有限公司的公告
2025-05-27 12:18
关于吸收合并全资子公司南京金宫实业有限公司的 公告 本公司及董事会全体成员保证公告内容的真实、准确、完整,没有 虚假记载、误导性陈述或重大遗漏。 南京公用发展股份有限公司(以下简称"公司")于 2025 年 5 月 27 日召开 第十二届董事会第十一次会议,审议通过了《关于吸收合并全资子公司南京金宫 实业有限公司的议案》,现将具体情况公告如下: 证券代码:000421 股票简称:南京公用 公告编号:2025-35 南京公用发展股份有限公司 一、吸收合并概述 2、根据《深圳证券交易所股票上市规则》的规定,本次吸收合并不构成关 联交易,亦不构成《上市公司重大资产重组管理办法》规定的重大资产重组,无 须相关部门的审批。 3、根据《公司法》及《公司章程》的规定,本次吸收合并尚需提交公司股 东大会审议,并经出席会议的股东所持有效表决权的三分之二以上通过方可生 效。 二、被合并方的基本情况 1、公司名称:南京金宫实业有限公司 2、注册资本:1,143.86 万元 3、公司类型:有限责任公司(非自然人投资或控股的法人独资) 4、法定代表人:丁明 5、经营范围:客运服务(按客运经营许可证范围经营);汽车租赁;企业管 1 理咨 ...
5月27日晚间重要公告一览
Xi Niu Cai Jing· 2025-05-27 10:16
Group 1 - Guangdian Electric's wholly-owned subsidiary plans to sell 5.91% stake in Shanghai Winshun Electric Technology Co., Ltd. to Yapp Automotive Parts Co., Ltd. for 62.63 million yuan, aiming to optimize asset structure [1] - Anhui Natural Gas received approval for the registration of 500 million yuan short-term financing bonds and 600 million yuan medium-term notes, valid for two years [1] - Kirin Security received government subsidies totaling 6.48 million yuan, which are related to revenue [2] Group 2 - Junshi Biosciences received approval for two new indications for its self-developed drug, Oncorhynchus monoclonal antibody injection, targeting adult patients with heterozygous familial hypercholesterolemia and non-familial hypercholesterolemia [3] - China Resources Double Crane's subsidiary passed GMP compliance inspection for small and large volume injection production lines [4] - Nanjing Public Utilities' board approved the absorption and merger of its wholly-owned subsidiary, Nanjing Jinguang Industry Co., Ltd. [7] Group 3 - Boya Bio received drug registration certificate for human immunoglobulin (pH4) in the Dominican Republic, valid until August 12, 2029 [8] - Jizhi Co. announced that its controlling shareholder and actual controller committed not to reduce their shareholdings until December 31, 2025 [9] - Yuhua Tian won a bid for the integrated urban management project in Lanzhou City, with a total service subsidy of 353 million yuan [10] Group 4 - Anke Rui obtained five invention patent certificates related to various energy management and control technologies [11] - Kebo Da's wholly-owned subsidiary plans to acquire 100% of Czech IMI Company for approximately 9.43 million euros to enhance global production layout [13] - Yantian Port announced a cash dividend of 1.30 yuan per 10 shares, totaling 676 million yuan [14] Group 5 - Huawang Technology plans to distribute a cash dividend of 0.45 yuan per share and a capital reserve increase of 0.20 shares per share [15] - Kabe Yi established a wholly-owned subsidiary in Japan to enhance its business layout [16] - Dongcheng Pharmaceutical's subsidiary received approval for the marketing of sodium fluoride injection, a PET radiopharmaceutical [18] Group 6 - Huaxin New Materials' subsidiary received two utility model patent certificates for innovative devices [19] - Lingang Steel's new 2290 cubic meter blast furnace has been successfully put into operation [21] - Xinlitai received drug registration certificate for Sacubitril/Valsartan tablets, the first of its kind in China [23] Group 7 - Aike Co.'s subsidiary received project designation notices from multiple clients for electric drive platform components [25] - Tonghe Pharmaceutical received drug registration certificate for Apixaban in South Korea [26] - Junting Hotel signed a cooperation agreement with Choice Hotels for exclusive brand usage in mainland China [28] Group 8 - Guangdong Hongtu plans to establish a wholly-owned subsidiary in Zhengzhou to enhance market layout [30] - Yuheng Pharmaceutical signed a joint promotion agreement for Pemafibrate tablets with Xinghe Pharmaceutical [31] - Chongqing Steel terminated the absorption and merger of its wholly-owned subsidiary, citing strategic advantages of independent operation [33] Group 9 - Jihong Co. announced the listing of its H-shares on the Hong Kong Stock Exchange [34] - Deshi Co. announced plans for shareholders to reduce their holdings by up to 0.3% [36] - Xinhai Medical's subsidiary received medical device registration for a dialysis fluid filter [42]
南京公用: 重大信息内部报告制度
Zheng Quan Zhi Xing· 2025-05-27 09:25
南京公用发展股份有限公司 二○二五年五月 南京公用发展股份有限公司 第一章 总 则 第一条 为规范南京公用发展股份有限公司(以下简称"公司")的重大信息 内部报告工作,保证公司内部重大信息的传递、归集和有效管理,使公司能够真 实、准确、完整、及时、充分地履行信息披露义务,维护投资者的合法权益,依 据《中华人民共和国公司法》 《中华人民共和国证券法》 《上市公司信息披露管理 办法》 《深圳证券交易所股票上市规则》 《深圳证券交易所上市公司自律监管指引 第1号——主板上市公司规范运作》等法律、规章及《公司章程》的有关规定, 结合公司的实际情况,制定本制度。 第二条 公司重大信息内部报告制度是指当出现、发生或即将发生可能对公 司股票及其衍生品种的交易价格产生较大影响的情形或事件出现时,按照本制度 规定负有报告义务的报告人应及时将相关信息向公司报告的制度。 第三条 本制度所称"信息报告义务人"是指公司及其董事、高级管理人员、 股东、实际控制人,收购人,重大资产重组、再融资、重大交易有关各方等自然 人、单位及其相关人员,破产管理人及其成员,以及法律、行政法规和中国证券 监督管理委员会(以下简称"中国证监会")规定的其他 ...
南京公用: 董事和高级管理人员所持本公司股份及其变动的管理制度
Zheng Quan Zhi Xing· 2025-05-27 09:25
General Principles - The management system for the shares held by the directors and senior management of Nanjing Public Utilities Development Co., Ltd. is established to strengthen the management of shareholding and changes in accordance with relevant laws and regulations [1][2] - Directors and senior management must be aware of laws prohibiting insider trading and market manipulation before trading the company's stocks [1][2] Registration - Directors and senior management are required to submit personal and family member information to the Shenzhen Stock Exchange within two trading days after their appointment or any changes in their information [2][3] - The company's securities affairs department must confirm the information submitted by directors and senior management and provide timely feedback [2][3] Transfer of Shares - Directors and senior management must notify the company's securities affairs department in writing before buying or selling company stocks, which will check for any potential issues [5][6] - Shares held by directors and senior management are subject to restrictions on transfer under certain conditions, such as during the lock-up period following a public offering [4][5] - The annual transferable share limit for directors and senior management is calculated based on 25% of the shares held as of the last trading day of the previous year [6][7] Information Disclosure - Directors and senior management must report any changes in their shareholding within two trading days and disclose relevant details on the designated website of the Shenzhen Stock Exchange [9][10] - Violations of trading regulations may result in the company recovering profits from directors and senior management, with required disclosures of the situation and remedial measures taken [9][10] Additional Regulations - Directors and senior management are prohibited from engaging in margin trading with the company's stocks [10] - The company's board of directors is responsible for formulating, revising, and interpreting the management system for shareholding [27][28]